Tetracycline Actions Relevant to Rosacea Treatment

被引:56
|
作者
Korting, H. C. [1 ]
Schoellmann, C. [1 ]
机构
[1] Univ Munich, Dept Dermatol & Allergol, DE-80337 Munich, Germany
关键词
Rosacea; Tetracyclines; Doxycycline; Inflammation; Matrix metalloproteinases; Cytokines; Reactive oxygen species; Angiogenesis; SUBANTIMICROBIAL-DOSE DOXYCYCLINE; CHEMICALLY-MODIFIED TETRACYCLINES; RANDOMIZED PHASE-III; DEMODEX-FOLLICULORUM; OCULAR ROSACEA; NITRIC-OXIDE; MATRIX METALLOPROTEINASES; CHRONIC PERIODONTITIS; TOPICAL THERAPIES; GINGIVAL TISSUE;
D O I
10.1159/000235550
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Until today, the pathogenesis of rosacea is not known in detail. Yet in recent years evidence has been accumulating that rosacea with its common symptoms such as inflammatory lesions, erythema, telangiectasia, phymatous changes, and ocular symptoms is of inflammatory nature. Tetracycline derivatives like doxycycline successfully used in the treatment of skin diseases like acne and rosacea seem to inhibit different inflammatory pathways involved in the pathogenesis by various modes of action. Although data for skin diseases are relatively scanty, the following modes of action of tetracyclines seem to be most relevant for an effective treatment of acne and rosacea: inhibition of matrix metalloproteinases, downmodulation of cytokines, inhibition of cell movement and proliferation, inhibition of granuloma formation, inhibition of reactive oxygen species, nitric oxide, and angiogenesis, whereas inhibition of phospholipase A2 seems to be of lower importance. The role of the saprophytic mite Demodex folliculorum remains to be clarified. Additional studies are necessary to further elucidate how tetracyclines work in rosacea treatment. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:287 / 294
页数:8
相关论文
共 50 条
  • [21] An update on the treatment of rosacea
    Rivero, Alexis Lara
    Whitfeld, Margot
    AUSTRALIAN PRESCRIBER, 2018, 41 (01) : 20 - 24
  • [22] IL-1α and MMP-9 Tear Levels of Patients with Active Ocular Rosacea before and after Treatment with Systemic Azithromycin or Doxycycline
    Lam-Franco, Lorena
    Perfecto-Avalos, Yocanxochitl
    Patino-Ramirez, Beatriz E.
    Rodriguez Garcia, Alejandro
    OPHTHALMIC RESEARCH, 2018, 60 (02) : 109 - 114
  • [23] Xanthone Derivatives and Their Potential Usage in the Treatment of Telangiectasia and Rosacea
    Brezden, Katarzyna
    Waszkielewicz, Anna M.
    APPLIED SCIENCES-BASEL, 2024, 14 (10):
  • [24] THE TREATMENT OF ROSACEA WITH TOPICAL IVERMECTIN
    Ali, S. T.
    Alinia, H.
    Feldman, S. R.
    DRUGS OF TODAY, 2015, 51 (04) : 243 - 250
  • [25] Emerging Treatment Options for Rosacea
    Piyu Parth Naik
    Current Dermatology Reports, 2021, 10 : 243 - 253
  • [26] Treatment Options for Acne Rosacea
    Goldgar, Constance
    Keahey, David J.
    Houchins, John
    AMERICAN FAMILY PHYSICIAN, 2009, 80 (05) : 461 - 468
  • [27] A Review of the Diagnosis and Treatment of Rosacea
    Scheinfeld, Noah
    Berk, Thomas
    POSTGRADUATE MEDICINE, 2010, 122 (01) : 139 - 143
  • [28] Clinical features and treatment of rosacea
    Shin, Min Kyung
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (05): : 355 - 363
  • [29] Role of laser in the treatment of rosacea
    Mazer, J. -M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 : S175 - S178
  • [30] Azithromycin in the treatment of papulopustular rosacea
    Dereli, T
    Inanir, I
    Kilinç, I
    Gençoglan, G
    JOURNAL OF DERMATOLOGY, 2005, 32 (11) : 926 - 928